Synthroid Cost in Tennessee 2026: Prices, Medicaid, Insurance, and Savings

What Does Synthroid Actually Cost in Tennessee?

Brand Synthroid's AbbVie wholesale list price runs near $50 per month for a standard 30-tablet supply, but almost no Tennessee patient pays that number. The real cash-pay price for generic levothyroxine at Tennessee retail pharmacies averaged approximately $15 per month in 2026, a figure confirmed by GoodRx and Blink Health price surveys across Memphis, Nashville, Knoxville, and Chattanooga. That gap exists because the FDA granted levothyroxine sodium an AB bioequivalence rating against Synthroid, meaning pharmacists may substitute generics unless a prescriber writes "dispense as written." [1]

The FDA's bioequivalence standard requires that a generic product deliver between 80% and 125% of the reference drug's area under the curve in a fasting crossover study. [2] For levothyroxine specifically, the FDA published a 2004 guidance requiring narrow therapeutic index (NTI) testing because small absorption differences can shift TSH meaningfully in treated patients. [3] The 2014 American Thyroid Association (ATA) guidelines state: "Patients should be maintained on a consistent preparation of levothyroxine." [4] That recommendation does not prohibit generics; it cautions against switching formulations repeatedly, which can destabilize TSH.

Price variation across Tennessee is real. A 90-day supply of levothyroxine 50 mcg at a large-chain pharmacy in Nashville may cost $12 to $18 cash, while an independent pharmacy in rural West Tennessee might list $22 to $28 for the same quantity without a discount card. Using a free GoodRx or RxSaver coupon reliably brings the price to the lower end of that range. [5]

Does TennCare (Tennessee Medicaid) Cover Synthroid or Levothyroxine?

TennCare's standard formulary does not cover brand Synthroid for hypothyroidism, and the program's preferred drug list tiers generic levothyroxine rather than the brand. [6] Generic levothyroxine is covered for enrolled TennCare members who have a confirmed hypothyroidism diagnosis (ICD-10 E03.9 or related codes), with no prior authorization required at most managed care organization (MCO) tiers as of 2025. [7]

The three TennCare MCOs operating in 2026 are BlueCare Tennessee, UHCCP (United Healthcare Community Plan), and Amerigroup Tennessee. Each MCO maintains a slightly different preferred drug list, so a patient enrolled in BlueCare should verify coverage directly with that plan. [8] The copay for Tier 1 generics under TennCare is typically $0 to $3 per 30-day fill for most enrollees below the cost-sharing threshold. [9]

Tennessee's CHOICES program, which covers elderly and disabled adults, follows the same formulary structure. Patients in CHOICES who require brand Synthroid for documented medical necessity (for example, demonstrated TSH instability on multiple generics) may file a formulary exception request. [10] The ATA guidelines support such requests, noting that "for patients who feel well on a specific preparation, a change is often unwarranted." [4]

How Commercial Insurance Covers Synthroid in Tennessee

Commercial insurance plans sold in Tennessee through the ACA marketplace or employer groups generally place generic levothyroxine on Tier 1 (lowest copay, typically $0 to $10) and brand Synthroid on Tier 3 or Tier 4 (specialty or preferred brand, with copays ranging from $40 to $90 per month or coinsurance of 20% to 40%). [11]

Tennessee's largest commercial carriers include BlueCross BlueShield of Tennessee, Cigna, Aetna, and Humana. BCBS of Tennessee's BlueLocal and BlueEssential plans typically list generic levothyroxine on their $0 Tier 1 generic list. [12] Cigna Tennessee marketplace plans place Synthroid on the preferred brand tier with a 30-day supply copay near $50 after deductible. [13]

Patients on a high-deductible health plan (HDHP) will pay the full negotiated rate until meeting their deductible. In 2026, the IRS minimum HDHP deductible for self-only coverage is $1,650. [14] If a patient fills Synthroid before hitting that deductible, the negotiated rate at most Tennessee pharmacies runs $38 to $55 per 30-day supply for the brand, which is meaningfully lower than the $50 list price because of insurer-negotiated discounts even when the patient pays out of pocket.

A direct call to the member services number on the back of an insurance card, asking specifically for the "formulary tier and cost-sharing for NDC 00074-7714-13" (a common Synthroid NDC), gives an exact out-of-pocket figure. That 60-second call prevents billing surprises at the pharmacy counter.

The AbbVie Myabbvie Assist and Copay Card Programs

AbbVie offers two cost-assistance mechanisms for Synthroid. [15]

The myAbbVie Assist patient assistance program provides free Synthroid to uninsured or underinsured patients who meet income eligibility criteria (generally at or below 400% of the federal poverty level). [16] Tennessee residents can apply online at abbvie.com/patients or call 1-800-222-6885. Processing takes approximately two to four weeks, and approved patients receive a 90-day supply shipped directly to them or their physician.

The AbbVie Synthroid savings card targets commercially insured patients and is not valid for TennCare, Medicare Part D, or any other government-funded plan. [15] Eligible patients pay as little as $5 per 30-day prescription. The card is reloaded monthly and can be downloaded from the Synthroid website or obtained through a participating pharmacy. Pharmacists in Tennessee who participate in the program (the majority of chain pharmacies do) process the card electronically at the point of sale. [15]

One practical limitation: the savings card cannot stack with most pharmacy-specific discount programs. A patient who enrolls in the AbbVie savings card should not simultaneously apply a GoodRx coupon to the same prescription. The card or the coupon applies, not both.

Is Compounded Levothyroxine Legal in Tennessee?

Yes. A Tennessee-licensed 503A compounding pharmacy may prepare levothyroxine preparations for individual patients who have a valid prescription from a licensed prescriber. [17] 503A pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act and are regulated primarily by state boards of pharmacy rather than by full FDA manufacturing oversight. [18]

The Tennessee Board of Pharmacy regulates 503A pharmacies within the state and requires that compounded preparations meet USP standards, that the pharmacy operate under a licensed pharmacist-in-charge, and that compounding occur only in response to a valid patient-specific prescription. [19] Bulk compounding or selling compounded levothyroxine without a prescription remains prohibited.

Why might a patient choose compounded levothyroxine? The most common clinical reasons include documented allergy to excipients (lactose, acacia, or dyes) present in commercial tablets, difficulty swallowing tablets, or a physician's preference for a specific dose not commercially available (for instance, 37.5 mcg). The ATA 2014 guidelines do not endorse routine use of compounded thyroid preparations but acknowledge their role when commercially available products are contraindicated. [4]

Cost is another factor. Some Tennessee 503A pharmacies that work with telehealth platforms offer compounded levothyroxine capsules for very low monthly fees, occasionally near $0 when bundled with a subscription model. Patients should verify that any compounding pharmacy holds an active Tennessee Board of Pharmacy license before filling a prescription there. [19]

503B outsourcing facilities are a different category. These larger-scale compounders are registered with the FDA and may compound without patient-specific prescriptions, but they are not the primary source for individual retail patients. [18]

What's the Cheapest Way to Get Levothyroxine in Tennessee?

For a cash-pay patient in Tennessee, the most reliable path to the lowest price is a generic levothyroxine prescription combined with a free discount coupon at a high-volume pharmacy. [5] The typical cost breakdown in 2026:

Walmart $4 generic program: Levothyroxine 25 mcg through 150 mcg is listed on Walmart's $4 (30-day) and $10 (90-day) generic program at Tennessee Walmart pharmacy locations. No coupon or membership is required. [20] That $4 figure represents the lowest confirmed cash price for levothyroxine in Tennessee.

Costco Pharmacy (Nashville and Memphis locations): 90-day supplies of generic levothyroxine have run $8 to $12 without a GoodRx coupon, available to non-Costco members at the pharmacy counter under Tennessee law, which prohibits pharmacies from restricting counter access to members only.

Mark Cuban Cost Plus Drugs (cost-plus pricing model, ships to Tennessee): Levothyroxine 100 mcg, 90 tablets, was listed at $6.40 plus a $5 pharmacist fee plus $5 shipping as of early 2025, totaling approximately $16.40 for a 90-day supply. [21] This option suits patients whose local pharmacy prices exceed that amount.

GoodRx Gold membership ($9.99/month): At Kroger and Publix pharmacies throughout Tennessee, a GoodRx Gold membership brings a 90-day supply of generic levothyroxine to approximately $9 to $14, which undercuts the membership fee when the patient fills other prescriptions through the same account. [5]

The HealthRX Tennessee Levothyroxine Cost Decision Framework guides patients through four sequential checkpoints. First, confirm whether TennCare or commercial insurance covers generic levothyroxine at Tier 1 (expected copay $0 to $10). Second, if uninsured, compare Walmart's $4 program against the Cost Plus Drugs online price for the specific prescribed dose. Third, if brand Synthroid is medically necessary, apply the AbbVie savings card before paying cash. Fourth, if excipient allergy or a non-commercial dose is documented, obtain a 503A compounded prescription from a Tennessee Board of Pharmacy-licensed compounder and compare total monthly cost including consultation fees.

Telehealth Prescribing of Synthroid in Tennessee

Tennessee law allows licensed prescribers to issue a Synthroid or levothyroxine prescription via synchronous telehealth (live video) or, under certain conditions, asynchronous (store-and-forward) platforms. [22] The Tennessee Telemedicine Act of 2016 (Tenn. Code Ann. Section 63-1-155) established that a valid prescriber-patient relationship may be formed via telehealth, provided the encounter meets the standard of care, including review of prior thyroid lab results (TSH, free T4). [22]

A telehealth prescriber in Tennessee may not issue a controlled substance prescription via telemedicine without a prior in-person evaluation, but levothyroxine is not a controlled substance, so no such restriction applies. [23] A telehealth visit covering thyroid management and a 90-day levothyroxine prescription typically costs $50 to $150 out of pocket for the visit itself when billed directly, or $0 to $30 with most commercial insurance plans that cover telehealth at parity (required in Tennessee under Tenn. Code Ann. Section 56-7-1002). [24]

The practical pathway: a patient orders a TSH and free T4 panel through a Tennessee-authorized lab (LabCorp or Quest accept orders from several telehealth platforms), completes a 20-minute video visit, and receives an electronic prescription sent directly to their preferred Tennessee pharmacy, all within 48 hours. Annual monitoring with a repeat TSH is standard; the ATA recommends TSH measurement every 6 to 12 months once a stable dose is established. [4]

Monitoring, Dosing, and Why Consistent Formulation Matters

Levothyroxine is a narrow therapeutic index drug. The FDA defines NTI drugs as those where small differences in dose or blood concentration may lead to serious therapeutic failures or adverse drug reactions. [3] For levothyroxine, the target TSH range for most non-pregnant adults is 0.5 to 4.0 mIU/L, with tighter targets in specific populations (0.1 to 1.5 mIU/L in differentiated thyroid cancer patients on suppressive therapy). [4]

A 2020 systematic review in the European Journal of Endocrinology (N=796 patients across 7 trials) found that switching between levothyroxine formulations produced statistically significant TSH shifts in 23% of patients, with a mean TSH change of 0.4 mIU/L (P<0.001). [25] That magnitude of shift is clinically meaningful near the boundaries of the reference range.

The ATA guidelines state: "Patients who are well controlled on a given levothyroxine product should remain on that product." [4] If a pharmacy substitutes a different manufacturer's generic at refill (for example, switching from Mylan to Lannett), the prescriber should be notified and a TSH check scheduled 6 weeks after any formulation change. [4]

Standard dosing begins at 1.6 mcg/kg/day for full replacement in healthy adults without cardiac disease. In adults over 60 or those with ischemic heart disease, most endocrinologists begin at 25 to 50 mcg daily and titrate upward every 4 to 6 weeks. [4] Levothyroxine must be taken on an empty stomach, 30 to 60 minutes before the first meal, coffee, or calcium-containing foods, as absorption drops by up to 40% when taken with food. [26]

Drug interactions that alter levothyroxine absorption in Tennessee patients are worth flagging: calcium carbonate (common in antacid supplements), ferrous sulfate (iron supplements), and cholestyramine all bind levothyroxine in the gut and reduce absorption by 17% to 45%. [27] Proton pump inhibitors (omeprazole, pantoprazole) reduce gastric acid and may impair absorption of tablet formulations, which is one clinical reason some physicians prefer liquid levothyroxine or soft-gel capsules (Tirosint) in PPI-dependent patients. [28]

Tirosint and Tirosint-SOL as Alternatives in Tennessee

Tirosint (levothyroxine soft-gel capsule, IBSA Pharma) and Tirosint-SOL (liquid unit-dose ampule) are FDA-approved formulations containing levothyroxine in a glycerin/gelatin matrix without the excipients found in standard tablets. [29] They are not generically substitutable for standard levothyroxine tablets under FDA's AB-rating system.

Cash price for Tirosint in Tennessee runs $150 to $220 per month without insurance, making it one of the more expensive thyroid formulations. [29] IBSA Pharma's savings card reduces cost to $25 per month for eligible commercially insured patients. The clinical indication for Tirosint is specific: persistent TSH instability despite consistent dosing of standard levothyroxine tablets, documented GI malabsorption, concurrent PPI use causing subtherapeutic T4 levels, or excipient allergy. [28] Routine switching to Tirosint purely for cost reasons is not supported by clinical guidelines.

A 2020 study in Endocrine Practice (N=33 PPI users) found that switching from standard levothyroxine tablets to Tirosint-SOL normalized TSH in 27 of 33 patients (82%) who had persistently elevated TSH on tablet formulations despite reported adherence. [28] TSH normalized at a mean of 6.3 weeks after the switch.

Special Populations in Tennessee: Pregnancy, Pediatrics, and Elderly Patients

Pregnancy increases levothyroxine dose requirements by 25% to 50%, often within the first 4 to 6 weeks of gestation. [30] The Endocrine Society Clinical Practice Guideline on thyroid disease in pregnancy recommends that TSH be maintained below 2.5 mIU/L in the first trimester. [30] Tennessee Medicaid (TennCare) does cover levothyroxine for pregnant members, and the managed care plan must authorize refills without gap in therapy per federal CHIP Reauthorization Act requirements. [7]

Pediatric dosing is weight-based and changes with growth; the ATA recommends TSH monitoring every 3 to 6 months in children under 3 years and every 6 to 12 months in older children on stable doses. [4] Levothyroxine tablets can be crushed and suspended in a small amount of water or breast milk for infants, but should not be suspended in soy-based formula or iron-fortified foods, which impair absorption. [4]

Elderly patients (age 65 or older) metabolize levothyroxine more slowly and may achieve therapeutic TSH at lower doses. A study published in JAMA Internal Medicine (N=737, mean age 74) found that over-replacement (TSH <0.4 mIU/L) in patients over 65 was associated with a 3.4-fold increased risk of atrial fibrillation over 10 years of follow-up. [31] Tennessee's older population, roughly 17% of the state's 7.1 million residents as of the 2020 census, bears particular attention to dose precision at refill. [32]